Gulsen Kama

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gulsen Kama:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bionano Genomics, Inc. Chief Financial Officer Common Stock 16,000 $20,320 $1.27 03 Jun 2024 Direct
Bionano Genomics, Inc. Chief Financial Officer Stock Option (Right to Buy) 75,000 03 Jun 2024 Direct
Bionano Genomics, Inc. Chief Financial Officer No securities are beneficially owned 0 11 Sep 2023 Direct

Insider Reports Filed by Gulsen Kama

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BNGO Bionano Genomics, Inc. 03 Jun 2024 2 $0 4 Chief Financial Officer 05 Jun 2024, 17:48
BNGO Bionano Genomics, Inc. 18 Sep 2023 1 $0 4 Chief Financial Officer 20 Sep 2023, 18:21
BNGO Bionano Genomics, Inc. 11 Sep 2023 0 $0 3 Chief Financial Officer 20 Sep 2023, 18:14